Institutional Ownership
Aurinia Pharmaceuticals Inc
CUSIP 05156V102COMAUPHQ1 2026
13D / 13G Filings
28
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
9.2%
Max % of class reported
Institutional Holders
252
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
28 filings · latest Mar 3, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 3, 2026 | Tang Capital Management, LLC | 13D/A | 9.2% | — | SEC |
| 2 | Aug 13, 2025 | Iljin Snt Co., Ltd. | 13D/A | 5.0% | — | SEC |
| 3 | Mar 4, 2025 | Tang Capital Management, LLC | 13D/A | 7.3% | — | SEC |
| 4 | Feb 14, 2025 | Armistice Capital, LLC | 13G/A | 4.5% | 6.40M | SEC |
| 5 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 5.7% | 8.20M | SEC |
| 6 | Sep 12, 2024 | Tang Capital Management LLC | 13D | 5.1% | 7.23M | SEC |
| 7 | Mar 20, 2024 | Iljin Snt Co., Ltd. | 13D/A | 4.4% | 6.40M | SEC |
| 8 | Feb 14, 2024 | Armistice Capital, LLC | 13G | 6.6% | 9.54M | SEC |
| 9 | May 10, 2023 | Iljin Snt Co., Ltd. | 13D/A | 4.2% | 6.06M | SEC |
| 10 | Feb 14, 2023 | Deep Track Capital, LP | 13G/A | 0.2% | 324.2K | SEC |
18 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Aurinia Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Tang Capital Management LLC | 12.23M | $181.24M |
| 2 | Blackrock, Inc. | 7.85M | $116.27M |
| 3 | Nea Management Company, LLC | 3.97M | $58.83M |
| 4 | Two Sigma Investments, LP | 3.43M | $50.81M |
| 5 | Arrowstreet Capital, Limited Partnership | 3.28M | $48.67M |
| 6 | State Street Corp | 2.53M | $37.45M |
| 7 | Morgan Stanley | 2.23M | $33.09M |
| 8 | Marshall Wace, LLP | 1.87M | $27.78M |
| 9 | Renaissance Technologies LLC | 1.66M | $24.66M |
| 10 | D. E. Shaw & Co., Inc. | 1.57M | $23.31M |